DK408289D0 - Diagnostisk reagens - Google Patents

Diagnostisk reagens

Info

Publication number
DK408289D0
DK408289D0 DK408289A DK408289A DK408289D0 DK 408289 D0 DK408289 D0 DK 408289D0 DK 408289 A DK408289 A DK 408289A DK 408289 A DK408289 A DK 408289A DK 408289 D0 DK408289 D0 DK 408289D0
Authority
DK
Denmark
Prior art keywords
antibody
fibrinolytic enzyme
fibrinolytic
increased
vivo
Prior art date
Application number
DK408289A
Other languages
English (en)
Inventor
Johan Selmer
Niels Tromholt
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Priority to DK408289A priority Critical patent/DK408289D0/da
Publication of DK408289D0 publication Critical patent/DK408289D0/da
Priority to DE90912800T priority patent/DE69002769T2/de
Priority to ES90912800T priority patent/ES2058931T3/es
Priority to NZ234937A priority patent/NZ234937A/xx
Priority to DK90912800.1T priority patent/DK0487594T3/da
Priority to AU62859/90A priority patent/AU639940B2/en
Priority to DD90343498A priority patent/DD297064A5/de
Priority to AT90912800T priority patent/ATE92770T1/de
Priority to KR1019920700340A priority patent/KR920703120A/ko
Priority to PCT/DK1990/000210 priority patent/WO1991002546A1/en
Priority to JP2512113A priority patent/JPH04507254A/ja
Priority to EP90912800A priority patent/EP0487594B1/en
Priority to CA002065147A priority patent/CA2065147A1/en
Priority to IL9540790A priority patent/IL95407A/en
Priority to IE297790A priority patent/IE65525B1/en
Priority to US07/569,127 priority patent/US5165912A/en
Priority to CS904047A priority patent/CZ280904B6/cs
Priority to NO92920624A priority patent/NO920624L/no
Priority to FI920669A priority patent/FI920669A0/fi

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/972—Plasminogen activators
    • G01N2333/9726—Tissue plasminogen activator

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DK408289A 1989-08-18 1989-08-18 Diagnostisk reagens DK408289D0 (da)

Priority Applications (19)

Application Number Priority Date Filing Date Title
DK408289A DK408289D0 (da) 1989-08-18 1989-08-18 Diagnostisk reagens
CA002065147A CA2065147A1 (en) 1989-08-18 1990-08-16 Reagent for the detection of fibrinolytic activity
KR1019920700340A KR920703120A (ko) 1989-08-18 1990-08-16 선유소 용해 활성 검출 시약
JP2512113A JPH04507254A (ja) 1989-08-18 1990-08-16 線維素溶解活性検出用試薬
NZ234937A NZ234937A (en) 1989-08-18 1990-08-16 Diagnostic reagent comprising a labelled antibody against a fibrinolytic enzyme and its use in detection of an enzyme associated with thromboses
DK90912800.1T DK0487594T3 (da) 1989-08-18 1990-08-16 Reagens til detektion af fibrinolytisk aktivitet
AU62859/90A AU639940B2 (en) 1989-08-18 1990-08-16 A reagent for the detection of fibrinolytic activity
DD90343498A DD297064A5 (de) 1989-08-18 1990-08-16 Reagens zum nachweis der fibrinolytischen aktivitaet
AT90912800T ATE92770T1 (de) 1989-08-18 1990-08-16 Mittel zum nachweis einer fibrinolytischen wirkung.
DE90912800T DE69002769T2 (de) 1989-08-18 1990-08-16 Mittel zum nachweis einer fibrinolytischen wirkung.
PCT/DK1990/000210 WO1991002546A1 (en) 1989-08-18 1990-08-16 A reagent for the detection of fibrinolytic activity
ES90912800T ES2058931T3 (es) 1989-08-18 1990-08-16 Un reactivo para la deteccion de actividad fibrinolitica.
EP90912800A EP0487594B1 (en) 1989-08-18 1990-08-16 A reagent for the detection of fibrinolytic activity
CS904047A CZ280904B6 (cs) 1989-08-18 1990-08-17 Diagnostické činidlo pro detekci zvýšené hladiny fibrinolytického enzymu
IL9540790A IL95407A (en) 1989-08-18 1990-08-17 Reagent, preparation and method for detecting fibrinolytic activity
IE297790A IE65525B1 (en) 1989-08-18 1990-08-17 A reagent for the detection of fibrinolytic activity
US07/569,127 US5165912A (en) 1989-08-18 1990-08-17 Method for the detection of fibrinolytic activity
NO92920624A NO920624L (no) 1989-08-18 1992-02-17 Reagens for paavisning av fibrinolytisk aktivitet
FI920669A FI920669A0 (fi) 1989-08-18 1992-02-17 Reagens foer detektion av fibrinolytisk aktivitet.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK408289A DK408289D0 (da) 1989-08-18 1989-08-18 Diagnostisk reagens

Publications (1)

Publication Number Publication Date
DK408289D0 true DK408289D0 (da) 1989-08-18

Family

ID=8129992

Family Applications (2)

Application Number Title Priority Date Filing Date
DK408289A DK408289D0 (da) 1989-08-18 1989-08-18 Diagnostisk reagens
DK90912800.1T DK0487594T3 (da) 1989-08-18 1990-08-16 Reagens til detektion af fibrinolytisk aktivitet

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK90912800.1T DK0487594T3 (da) 1989-08-18 1990-08-16 Reagens til detektion af fibrinolytisk aktivitet

Country Status (18)

Country Link
US (1) US5165912A (da)
EP (1) EP0487594B1 (da)
JP (1) JPH04507254A (da)
KR (1) KR920703120A (da)
AT (1) ATE92770T1 (da)
AU (1) AU639940B2 (da)
CA (1) CA2065147A1 (da)
CZ (1) CZ280904B6 (da)
DD (1) DD297064A5 (da)
DE (1) DE69002769T2 (da)
DK (2) DK408289D0 (da)
ES (1) ES2058931T3 (da)
FI (1) FI920669A0 (da)
IE (1) IE65525B1 (da)
IL (1) IL95407A (da)
NO (1) NO920624L (da)
NZ (1) NZ234937A (da)
WO (1) WO1991002546A1 (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6964764B2 (en) * 1999-11-13 2005-11-15 Talecris Biotherapeutics, Inc. Method of thrombolysis by local delivery of reversibly inactivated acidified plasmin
US7544500B2 (en) * 1999-11-13 2009-06-09 Talecris Biotherapeutics, Inc. Process for the production of a reversibly inactive acidified plasmin composition
US6355243B1 (en) * 1999-11-13 2002-03-12 Bayer Corporation Method of thrombolysis by local delivery of active plasmin
US20080167544A1 (en) * 2006-12-01 2008-07-10 Cold Spring Diagnostics, Inc. Compositions And Methods For Locating An Internal Bleeding Site
AU2009256168B2 (en) * 2008-06-04 2014-06-05 Grifols Therapeutics Inc. Composition, method and kit for preparing plasmin
US9206410B2 (en) 2009-03-03 2015-12-08 Grifols Therapeutics Inc. Compositions, methods and kits for preparing plasminogen and plasmin prepared therefrom

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61501321A (ja) * 1984-01-23 1986-07-03 インスティテュト・フォ−・エネジテクニク たんぱく様物質標識用テクネチウム９９ｍ組成物およびその使用方法
US4659839A (en) * 1984-10-10 1987-04-21 Mallinckrodt, Inc. Coupling agents for radiolabeled antibody fragments
CA1285223C (en) * 1986-11-10 1991-06-25 New England Deaconess Hospital Detection of vascular disease

Also Published As

Publication number Publication date
DD297064A5 (de) 1992-01-02
IE902977A1 (en) 1991-02-27
IL95407A0 (en) 1991-06-30
FI920669A0 (fi) 1992-02-17
JPH04507254A (ja) 1992-12-17
WO1991002546A1 (en) 1991-03-07
DE69002769T2 (de) 1993-12-02
EP0487594A1 (en) 1992-06-03
CA2065147A1 (en) 1991-02-19
NO920624D0 (no) 1992-02-17
DE69002769D1 (de) 1993-09-16
US5165912A (en) 1992-11-24
KR920703120A (ko) 1992-12-17
ATE92770T1 (de) 1993-08-15
AU639940B2 (en) 1993-08-12
CZ280904B6 (cs) 1996-05-15
IE65525B1 (en) 1995-11-01
CZ404790A3 (en) 1996-01-17
EP0487594B1 (en) 1993-08-11
NZ234937A (en) 1991-11-26
ES2058931T3 (es) 1994-11-01
IL95407A (en) 1994-07-31
AU6285990A (en) 1991-04-03
DK0487594T3 (da) 1994-01-03
NO920624L (no) 1992-02-17

Similar Documents

Publication Publication Date Title
EP0217577A3 (en) Antibody complexes of hapten-modified diagnostic or therapeutic agents
SE8902638L (sv) Stabiliserade protein- eller peptidkonjugat
HK1002833A1 (en) Method and apparatus for amperometric diagnostic analysis
ATE162403T1 (de) Modifizierte antikörper mit kontrollierter clearance-zeit
ES2061459T3 (es) Procedimiento de ensayo de substancias fisiologicamente activas.
DE69822164D1 (de) Verfahren zur identifizierung von verbindungen mit verminderter systemischer aktivität
DK408289D0 (da) Diagnostisk reagens
SE7903821L (sv) Kinetisk metning av glykoskoncentrationen i kroppsvetskor och beredning herfor
DE69028095T2 (de) M-csf-monoklonale antikörper, die ein neutralisierendes konformationales epitop erkennen
NZ332641A (en) method of detecting a lysosomal storage disorder by assaying the level of an enzyme, protein or peptide associated with the disease
ES2067024T3 (es) Metodo y kit para determinar actividades fosforilantes y desfosforilantes de tirosina.
DE3478958D1 (en) Protein conjugates of penicilloic acid, their preparation and use
ES2088427T3 (es) Ensayo simultaneo de dos analitos.
FI881122A (fi) Menetelmä tyvikalvoproteiinien eristämiseksi ihmis- ja eläinkudoksista
ES8707798A1 (es) Un procedimiento para analizar una muestra de tejido para determinar la presencia de antigeno de la hepatitis no a no b
AU3039589A (en) Method for detecting antibodies specific for rheumatic diseases, in particular chronic polyarthritis, and reagent therefor
WO2000051520A3 (en) Bovine pregnancy testing
DE69027441D1 (en) Ribozymenhemmer
GB2062226A (en) Reagent and method for the determination of human-muscle aldolase
EP0233048A3 (en) Method of detecting urinary tract infection or inflammation
AU573748B2 (en) Monoclonal antibody to cancer procoagulant and immunoassay
EP0241000A3 (en) Method for determination of complements
DK389584A (da) Fremgangsmaade til maerkning af fagocytceller
JPS5797450A (en) Measuring method for enzyme immunity by competitive combination method of hormone using regenerable immune adsorption body
NO177310C (no) Antigent polypeptid fra HBxAg, antistoff som reagerer med polypeptidet, diagnostisk analysesystem for bestemmelse av tilstedeværelsen av HBxAg i en kroppspröve, samt anvendelse av polypeptidet til in vitro diagnose

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment